Fact CheckerSign in

NCT07448532Recruiting

Comparative Effects of Functional Electrical Stimulation and Mirror Therapy for Foot Clearance Among Patients With Sub-acute Stroke

Source: ClinicalTrials.gov · Last updated 4 Mar 2026

Brief summary (registry, in English)

This study aims to evaluate the effectiveness of two rehabilitation techniques- Functional Electrical Stimulation (FES) and Mirror Therapy (MT)-in improving motor recovery among stroke survivors. Stroke often results in long-term impairments, particularly in foot clearance, which is critical for daily activities. Although current rehabilitation strategies help, more effective solutions are needed to enhance recovery. Participants, aged 18- 85 years old with subacute stroke and foot clearance impairments, will be randomized into two groups: Group A will receive functional electrical stimulation (FES) with routine physical therapy; and Group B will receive mirror therapy (MT) with routine physical therapy. The interventions will take place three times a week for 4 weeks, and participants will undergo motor function assessments, including the Fugl-Meyer Assessment and Functional Independence Measure, before and after the intervention. The study will compare the effects of each intervention on motor recovery, specifically focusing on tibialis anterior function and motor control. The findings could lead to improved rehabilitation protocols, offering stroke survivors better therapeutic options and enhancing their quality of life.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
38 (estimated)
First submitted
26 Feb 2026
Start date
22 Jan 2026
Primary completion date
22 Jun 2026
Lead sponsor
Lahore University of Biological and Applied Sciences
Diseases
Stroke
NCT number
NCT07448532

What you commit to

  • Study type: Interventional
  • Planned participants: 38
  • From 22 Jan 2026 to the primary completion date, 22 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with cardiac pacemaker, those with skin lesions, who could not be treated due to spasticity within the last three months, and vestibular and cerebellar lesions or deaf- blindness were excluded.
  • Patients with past or current epilepsy, uncontrolled seizure disorder, mental disorders and all neurological disorders except stroke.
  • Patients with severe edema of lower extremities or patients of vascular disorders like deep vein thrombosis or thromboembolisms and severe atheroscelerosis of lower extremities.

Other

  • Subjects with any musculoskeletal dysfunction that would potentially affect gait and causes risk of falls.
  • We excluded patients with pregnancy, plantar flexion contracture, and severe hemi-neglect.
  • Subjects with hip or knee prostheses made of metal on the lower limb were excluded.

Who the study is looking for

  • Patient aged 18-85 years of age, who experienced stroke within ≤6 months.
  • The Fugl-Meyer motor assessment of lower extremity (FMA-LE) was conducted by physiotherapist in the hospital, and score required to be ≥ 20 points.
  • Participants possessed healthy nerves, neuromuscular junctions, muscles tissues, and a sufficient range of motion in dorsiflexor and plantarflexion.
  • The subjects could walk independently on a treadmill for at least 2 min without without experiencing adverse reaction to FES.
  • Patients who received more 24 scores on Mini Mental State Exam and could comprehend and follow the information researcher provides.
  • No orthopedic diseases in upper and lower extremities.
  • Patients with functional ambulation classification (FAC) score of 3 or 4 were included (FAC is a scale of 0-5, where 3 indicates supervision or standby guarding and 4 indicates independent on level surfaces.
  • Patients with inadequate ankle dorsiflexion during the swing phase of gait.
  • Patients with adequate minimal stability at the ankle during stance with stimulation.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lahore University of Biological and Applied Sciences
Coordinator of this site? Confirm its status
LahorePakistanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.